comparemela.com
Latest Breaking News On - Agepha pharma - Page 5 : comparemela.com
FDA OKs Low-Dose Colchicine for Broad CV Indication
The drug represents the first specific anti-inflammatory drug for the reduction of cardiovascular events for patients with established atherosclerotic disease or with multiple risk factors.
Boston
Massachusetts
United-states
Agepha-pharma
Paul-ridker
Drug-administration
Cardiovascular-disease-prevention
Very-big-day
Colchicine's Rebirth as Cardiovascular Drug Approved by FDA
Repurposed anti-inflammatory drug may be used alone or in combination with standard meds
Boston
Massachusetts
United-states
Nicole-lou
Agepha-pharma
Paul-ridker
Harvard-medical-school
Medpage-today
vimarsana © 2020. All Rights Reserved.